Biocon to buy GE Capital stake in research services arm for $35 mn
Biocon said it would buy the stake in unit Syngene, which is involved in pharmaceutical contract research and manufacturing, from GE Equity International Mauritius.
Sep 09, 2014, 23:07 PM IST